The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...

Endometrial cancer (EC) ranks as the second most prevalent gynecologic malignancy globally, with approximately 189,000 new ...

Acrivon Therapeutics (ACRV) announced the U.S. Food and Drug Administration, FDA, has granted Breakthrough Device designation, BDD, for the ACR-368 OncoSignature assay, a multiplex immunofluorescence ...

PCOS can cause many additional health issues, including infertility and endometrial cancer, if it's symptoms are left ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.

In 2024, adults 65 and over became the largest age group of users of FAIR Health Consumer (fairhealthconsumer.org), FAIR Health's free, award-winning consumer website. Hundreds of thousands of users?a ...

We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...

Cannabidiol (CBD), the component in cannabis often used for therapeutic treatments, is increasingly being used during pregnancy as a means of managing symptoms such as nausea, anxiety and sleep.

Australia was introduced to Annabelle Natalie Gibson. Better known as Belle, the wellness influencer quickly rose to success when she revealed she had been beaten multiple cancers through a healthy ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...